High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma - Nadia Arang, Simone Lubrano, Michele Ceribelli, Damiano C. Rigiracciolo, Robert Saddawi-Konefka, Farhoud Faraji, Sydney I. Ramirez, Daehwan Kim, Frances A. Tosto, Erica Stevenson, Yuan Zhou, Zhiyong Wang, Julius Bogomolovas, Alfredo A. Molinolo, Danielle L. Swaney - Dissemin

Language
Login

Published in

Cell Press, Cell Reports Medicine, 11(4), p. 101244, 2023

DOI: 10.1016/j.xcrm.2023.101244

Links

Cell Press | PDF

Tools

Export citation

Search in Google Scholar

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma

Journal article published in 2023 by Nadia Arang, Simone Lubrano, Michele Ceribelli, Damiano C. Rigiracciolo, Robert Saddawi-Konefka, Farhoud Faraji, Sydney I. Ramirez, Daehwan Kim, Frances A. Tosto, Erica Stevenson, Yuan Zhou, Zhiyong Wang, Julius Bogomolovas, Alfredo A. Molinolo, Danielle L. Swaney and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO